Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001735276-22-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +5,026 | 5,026 | New | $0 |
| D | 2022-02-03 | 2022-02-02 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | F - Tax | $144.67 | -1,518 | 3,508 | -30% | -$219.6K |
| D | 2022-02-03 | 2022-02-01 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | -5,026 | 5,025 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | M | A | 5,026 | $0.00 | 5,026 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-02 | F | D | 1,518 | $144.67 | 3,508 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-02-01 | M | D | 5,026 | $0.00 | 5,025 | D | $0.00 · — to — | 5,026 Common Stock | (F2) On February 1, 2021 the reporting person received 10,051 restricted stock units, one-half of which vested on the first anniversary of the grant date, and one-half of which will vest on the second anniversary of the grant date. |